Skip to main content

Table 1 patient characteristics:

From: The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis

Characteristics

Group 1 Furosemide 40 mg (n = 8)

Group 2 Furosemide1 120 mg (n = 10)

P value

Age (years)

56.5 ± 9.6

54 ± 9.0

NS

Sex ratio (M/F)

5/3

6/4

NS

Etiology : Alcoholic

3

4

NS

   Non alcoholic

5

6

NS

Serum albumin(g/L)

39 ± 4

40 ± 5

NS

INR

1.09 ± 0.1

1.1 ± 0.1

NS

Bilirubin (micromol/L)

20.5 ± 34.9

18.8 ± 8.5

NS

Child-Pugh's score

5–6

5–6

NS

MELD score

7

8

NS

Serum sodium(mEq/L)

136 ± 1.0

137 ± 1.6

NS

Median (range)

136 (134–138)

136 (133–139)

 

Serum creatinine (micromol/L)

   

   Base line

77.8 ± 14

81.3 ± 15

NS

   After 1 week follow up

79.6 ± 13

82.2 ± 16.8

NS

Creatinine clearance (ml/min)

82.6 ± 30.4

89.8 ± 32.0

NS

Median (range)

73 (56–142)

92 (41–150)

 

8-hours UNa (before, median, range)

87 ± 26 (80, 60–122)

97 ± 32 (107, 37–128)

NS

8-hours UNa (After mEq, median, range)

100 ± 36 (96,42–147)

136 ± 37 (127, 92–213)

0.05

% Change

+15%

+40%

0.01

DMSA Uptake (Nl > 20%)

   

   Before Furosemide (median, range)

12.8 ± 3.8 (14, 3–17)

10.6 ± 4.6 (10, 3–21)

0.001

   After Furosemide (median, range)

15.2 ± 2.2 (16, 10–20)

13.5 ± 3.6 (15, 6–21)

0.001

% Change

+19%

+27%

 
 

p < 0.001

p = <0.003